| # | Drug | Count |
|---|---|---|
| 0 | BRENTUXIMAB VEDOTIN | 4 |
| 1 | DEXAMETHASONE SODIUM PHOSPHATE | 4 |
| 2 | PROMETHAZINE HYDROCHLORIDE | 4 |
| 3 | CYCLOPHOSPHAMIDE | 3 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 6 | DOXORUBICIN | 3 |
| 7 | SODIUM BICARBONATE | 3 |
| 8 | SODIUM BICARBONATE INJECTION, | 3 |
| 9 | SODIUM BICARBONATE, INJECTION | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 1 | GLUTATHIONE | 1 | 0.0006 |
| 2 | ESTAZOLAM | 1 | 0.0005 |
| 3 | DEXAMETHASONE SODIUM PHOSPHATE | 4 | 0.0004 |
| 4 | BRENTUXIMAB VEDOTIN | 4 | 0.0004 |
| 5 | EPIRUBICIN HYDROCHLORIDE | 2 | 0.0003 |
| 6 | ACARBOSE | 1 | 0.0003 |
| 7 | PROMETHAZINE HYDROCHLORIDE | 4 | 0.0002 |
| 8 | IRON SUCROSE | 2 | 0.0002 |
| 9 | SODIUM BICARBONATE INJECTION, | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 4 | 0.0004 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Parenteral Iron Replacement [EPC] | 2 | 0.0001 |
| 3 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |
| 5 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 2 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |